BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samarpita S, Kim JY, Rasool MK, Kim KS. Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug. Arthritis Res Ther 2020;22:16. [PMID: 31973752 DOI: 10.1186/s13075-020-2097-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Ren X, Zhang L, Wang Y, Chen T. Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals. Front Aging Neurosci 2022;14:901117. [DOI: 10.3389/fnagi.2022.901117] [Reference Citation Analysis]
2 Liu Z, Li W, Cao Y, Zhang X, Yang K, Yin F, Yang M, Peng P. Effects of the interaction of Notch and TLR4 pathways on inflammation and heart function in septic heart. Open Life Sci 2022;17:744-55. [PMID: 35891967 DOI: 10.1515/biol-2022-0076] [Reference Citation Analysis]
3 Zenobia C, Darveau RP. Does Oral Endotoxin Contribute to Systemic Inflammation? Front Oral Health 2022;3:911420. [DOI: 10.3389/froh.2022.911420] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ruiz VH, Encinas-basurto D, Sun B, Eedara BB, Dickinson SE, Wondrak GT, Chow H-S, Curiel-lewandrowski C, Mansour HM. Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery. Pharmaceutics 2022;14:700. [DOI: 10.3390/pharmaceutics14040700] [Reference Citation Analysis]
5 Cao Y, Liu J, Huang C, Tao Y, Wang Y, Chen X, Huang D. Wilforlide A ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization. J Pharmacol Sci 2022;148:116-24. [PMID: 34924115 DOI: 10.1016/j.jphs.2021.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu S, Zhang S, Sun Y, Zhou W. Transcriptomics Changes in the Peritoneum of Mice with Lipopolysaccharide-Induced Peritonitis. Int J Mol Sci 2021;22:13008. [PMID: 34884814 DOI: 10.3390/ijms222313008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Martu MA, Maftei GA, Luchian I, Stefanescu OM, Scutariu MM, Solomon SM. The Effect of Acknowledged and Novel Anti-Rheumatic Therapies on Periodontal Tissues-A Narrative Review. Pharmaceuticals (Basel) 2021;14:1209. [PMID: 34959607 DOI: 10.3390/ph14121209] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Farooq M, Batool M, Kim MS, Choi S. Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies. Front Cell Dev Biol 2021;9:756315. [PMID: 34671606 DOI: 10.3389/fcell.2021.756315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mikuls TR, Gaurav R, Thiele GM, England BR, Wolfe MG, Shaw BP, Bailey KL, Wyatt TA, Nelson AJ, Duryee MJ, Hunter CD, Wang D, Romberger DJ, Ascherman DP, Poole JA. The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease. Int Immunopharmacol 2021;100:108069. [PMID: 34461491 DOI: 10.1016/j.intimp.2021.108069] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Santos-Sierra S. Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One? Biomolecules 2021;11:1291. [PMID: 34572504 DOI: 10.3390/biom11091291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Unterberger S, Davies KA, Rambhatla SB, Sacre S. Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology. Immunotargets Ther 2021;10:285-98. [PMID: 34350135 DOI: 10.2147/ITT.S288547] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Roszkowski L, Ciechomska M. Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis. Cells 2021;10:1860. [PMID: 34440629 DOI: 10.3390/cells10081860] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol 2021;17:561-71. [PMID: 33787418 DOI: 10.1080/1744666X.2021.1908887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tsiklauri L, Švík K, Chrastina M, Poništ S, Dráfi F, Slovák L, Alania M, Kemertelidze E, Bauerova K. Bioflavonoid Robinin from Astragalus falcatus Lam. Mildly Improves the Effect of Metothrexate in Rats with Adjuvant Arthritis. Nutrients 2021;13:1268. [PMID: 33924354 DOI: 10.3390/nu13041268] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W. Biological drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B 2021;11:941-60. [PMID: 33996408 DOI: 10.1016/j.apsb.2020.12.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 28.0] [Reference Citation Analysis]
16 Manfredi A, Luppi F, Cassone G, Vacchi C, Salvarani C, Sebastiani M. Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia. Expert Rev Clin Immunol 2020;16:751-70. [PMID: 32722946 DOI: 10.1080/1744666X.2020.1803064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Low ZY, Farouk IA, Lal SK. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak. Viruses 2020;12:E1058. [PMID: 32972027 DOI: 10.3390/v12091058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
18 Federico S, Pozzetti L, Papa A, Carullo G, Gemma S, Butini S, Campiani G, Relitti N. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. J Med Chem 2020;63:13466-513. [PMID: 32845153 DOI: 10.1021/acs.jmedchem.0c01049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
19 Qing P, Liu Y. Inhibitory role of long non-coding RNA OIP5-AS1 in rheumatoid arthritis progression through the microRNA-448-paraoxonase 1-toll-like receptor 3-nuclear factor κB axis. Exp Physiol 2020;105:1708-19. [PMID: 32770578 DOI: 10.1113/EP088608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
20 Ichise Y, Saegusa J, Tanaka-Natsui S, Naka I, Hayashi S, Kuroda R, Morinobu A. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4. Cells 2020;9:E1689. [PMID: 32674360 DOI: 10.3390/cells9071689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]